Healthcare provider profile · identity verified

William J Artz, D.O.

Family Practice · PHILADELPHIA, PA · NPI 1154378891

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	486	148
Atorvastatin Calcium	Atorvastatin Calcium	436	132
Losartan Potassium	Losartan Potassium	378	104
Metoprolol Succinate	Metoprolol Succinate	372	116
Amlodipine Besylate	Amlodipine Besylate	343	106
Levothyroxine Sodium	Levothyroxine Sodium	256	81
Pantoprazole Sodium	Pantoprazole Sodium	231	69
Metformin Hcl	Metformin Hcl	215	62
Fluticasone Propionate	Fluticasone Propionate	208	70
Omeprazole	Omeprazole	189	56
Lisinopril	Lisinopril	185	60
Famotidine	Famotidine	178	53
Ezetimibe	Ezetimibe	168	48
Metoprolol Tartrate	Metoprolol Tartrate	153	48
Montelukast Sodium	Montelukast Sodium	151	43
Tamsulosin Hcl	Tamsulosin Hcl	141	41
Gabapentin	Gabapentin	137	35
Trazodone Hcl	Trazodone Hcl	131	41
Escitalopram Oxalate	Escitalopram Oxalate	121	38
Furosemide	Furosemide	114	38
Simvastatin	Simvastatin	114	32
Eliquis	Apixaban	110	31
Clopidogrel	Clopidogrel Bisulfate	101	24
Albuterol Sulfate Hfa	Albuterol Sulfate	96	32
Sertraline Hcl	Sertraline Hcl	94	27
Alprazolam	Alprazolam	85	32
Lorazepam	Lorazepam	85	33
Tramadol Hcl	Tramadol Hcl	84	22
Jardiance	Empagliflozin	83	22
Hydrochlorothiazide	Hydrochlorothiazide	72	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	68	19
Potassium Chloride	Potassium Chloride	66	19
Meloxicam	Meloxicam	64	20
Allopurinol	Allopurinol	63	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	58	18
Xarelto	Rivaroxaban	57	11
Donepezil Hcl	Donepezil Hcl	55	14
Oxycodone Hcl	Oxycodone Hcl	54	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	54	12
Duloxetine Hcl	Duloxetine Hcl	52	17
Ipratropium Bromide	Ipratropium Bromide	52	14
Methylprednisolone	Methylprednisolone	52	43
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	50	14
Celecoxib	Celecoxib	50	13
Pregabalin	Pregabalin	49	15
Citalopram Hbr	Citalopram Hydrobromide	48	11
Finasteride	Finasteride	48	16
Ibuprofen	Ibuprofen	47	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	13
Spironolactone	Spironolactone	47	11
Alendronate Sodium	Alendronate Sodium	46	16
Metformin Hcl Er	Metformin Hcl	46	12
Zolpidem Tartrate	Zolpidem Tartrate	46	16
Hydralazine Hcl	Hydralazine Hcl	44	17
Atenolol	Atenolol	41	15
Esomeprazole Magnesium	Esomeprazole Magnesium	41	suppressed
Ozempic	Semaglutide	41	13
Glimepiride	Glimepiride	39	14
Synthroid	Levothyroxine Sodium	38	14
Mirtazapine	Mirtazapine	37	14
Lidocaine	Lidocaine	36	15
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Valsartan	Valsartan	34	11
Clonazepam	Clonazepam	32	suppressed
Ramipril	Ramipril	32	12
Baclofen	Baclofen	31	11
Carvedilol	Carvedilol	31	11
Ketoconazole	Ketoconazole	31	suppressed
Novolog Flexpen	Insulin Aspart	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Diazepam	Diazepam	28	suppressed
Prednisone	Prednisone	27	14
Symbicort	Budesonide/Formoterol Fumarate	27	11
Tresiba Flextouch U-200	Insulin Degludec	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Ibandronate Sodium	Ibandronate Sodium	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Azelastine Hcl	Azelastine Hcl	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Nateglinide	Nateglinide	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Raloxifene Hcl	Raloxifene Hcl	20	suppressed
Repaglinide	Repaglinide	20	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Cephalexin	Cephalexin	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Topiramate	Topiramate	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Sotalol	Sotalol Hcl	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Amoxicillin	Amoxicillin	13	13
Buspirone Hcl	Buspirone Hcl	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Probenecid	Probenecid	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Movantik	Naloxegol Oxalate	12	suppressed
Naproxen	Naproxen	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Fluvastatin Er	Fluvastatin Sodium	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error